Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details)

v3.22.2.2
Stock-Based Compensation (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 06, 2020
Feb. 17, 2021
Mar. 31, 2021
Sep. 30, 2022
Dec. 31, 2020
Dec. 31, 2019
Jul. 15, 2021
Stock-Based Compensation (Details) [Line Items]              
Common stock, shares reserved for issuance             1,302,326
Increase in issuance of authorized shares 348,837 1,767,442          
Authorized for issuance         465,116    
Shares available for future grant         17,442    
Grant date fair value of options (in Dollars)       $ 11,000      
Unrecognized compensation cost       1,300,000      
Weighted average period       2 years 1 month 6 days      
Description of consulting exercised     During the three months ended March 31, 2021, employees and consultants exercised a total of 383,721 stock options and the Company received $119,000 in proceeds. A portion of these options were exercised early (prior to vesting), and as of September 30, 2022, 11,726 of the options remained unvested. Proceeds received related to the unvested options of approximately $38,000 at September 30, 2022 were recorded in accrued liabilities on the accompanying balance sheets and will be reclassified to equity as vesting occurs, provided the employees and consultants continue to provide services to the Company. Proceeds received related to the vested portion of options of $51,000 and $22,000 were reclassified to equity during the nine-month periods ended September 30, 2021 and 2022, respectively. The vested portion of the exercises was 371,988 shares at September 30, 2022.         
Expected dividend       0.00%      
2019 Plan [Member]              
Stock-Based Compensation (Details) [Line Items]              
Authorized for issuance of shares           232,558  
Shares issued for future grants           75,581